[HTML][HTML] Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy

EJ Song, KH Jeong, YA Yang, JH Lim… - Kidney research and …, 2018 - ncbi.nlm.nih.gov
Background Phospholipase A2 receptor (PLA2R) has been identified as a major
autoantigen in primary membranous nephropathy (MN). We evaluated the association …

Antibodies against M-type phospholipase A2 receptor may predict treatment response and outcome in membranous nephropathy

Z Qu, M Zhang, Z Cui, J Wang, M Wang… - American Journal of …, 2018 - karger.com
Background: Anti-phospholipase A2 receptor (PLA2R) antibodies are specific to the
diagnosis of primary membranous nephropathy (pMN). The prevalence of positive …

Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy

S Akiyama, M Akiyama, E Imai, T Ozaki… - Clinical and …, 2015 - Springer
Background Membranous nephropathy (MN) is the leading cause of nephrotic syndrome in
adults. Anti-M-type phospholipase A2 receptor (anti-PLA2R) antibodies are found in most …

Serum anti-PLA2R antibody predicts treatment outcome in idiopathic membranous nephropathy

SY Wei, YX Wang, JS Li, SL Zhao, TT Diao… - American Journal of …, 2016 - karger.com
Background: M-type phospholipase A 2 receptor (PLA 2 R) has been identified as the major
target antigen in idiopathic membranous nephropathy (IMN). However, the role of …

Autoantibodies against Phospholipase A2 Receptor in Korean Patients with Membranous Nephropathy

YJ Oh, SH Yang, DK Kim, SW Kang, YS Kim - PloS one, 2013 - journals.plos.org
The data were presented in abstract form at the 45th meeting of the American Society of
Nephrology, October 30-November 04 2012, San Diego, CA, USA. Circulating …

Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status …

P Yin, J Wang, W Liang, L Zhan, Y Liu, J Lin… - Renal …, 2020 - Taylor & Francis
Introduction Primary membranous nephropathy (PMN) is associated with the anti-
phospholipase A2 receptor (anti-PLA2R) antibody in 70% of cases. Some anti-PLA2R …

Anti-phospholipase A2 receptor (PLA2R) antibody and glomerular PLA2R expression in Japanese patients with membranous nephropathy

K Hihara, M Iyoda, S Tachibana, K Iseri, T Saito… - PLoS …, 2016 - journals.plos.org
The phospholipase A2 receptor (PLA2R) is the major target antigen (Ag) in idiopathic
membranous nephropathy (IMN). Recently, several types of immunoassay systems for anti …

Clinical usefulness of anti-M-type phospholipase-A-receptor antibodies in patients with membranous nephropathy and the comparison of three quantification methods

Y Katsumata, Y Okamoto, T Moriyama… - Immunological …, 2020 - Taylor & Francis
Associations between anti-M-type phospholipase A2 receptor (PLA2R) antibodies and
disease activity and prognosis have been suggested in primary membranous nephropathy …

[HTML][HTML] Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: A report from Iranian population

MR Ardalan, A Ghafari, F Hamzavi, H Nasri… - Journal of …, 2013 - ncbi.nlm.nih.gov
Background: Idiopathic Membranous Nephropathy (iMN) is the most common cause of
nephrotic syndrome in adults. Approximately one third of patients with iMN progress to end …

Anti-phospholipase A2 receptor antibody in membranous nephropathy

W Qin, LH Beck Jr, C Zeng, Z Chen, S Li… - Journal of the …, 2011 - journals.lww.com
The M-type phospholipase A2 receptor (PLA2R) is a target autoantigen in adult idiopathic
membranous nephropathy (MN), but the prevalence of autoantibodies against PLA2R is …